Evogene Schedules Second Quarter 2024 Financial Results Release

Core Insights - Evogene Ltd. will release its financial results for Q2 2024 on August 22, 2024, followed by a conference call at 9:00 AM ET [1] - The company focuses on leveraging big data and artificial intelligence to enhance life-science product development [2] Company Overview - Evogene Ltd. is a computational biology company aiming to revolutionize life-science product discovery and development through advanced technologies [2] - The company has established three unique tech-engines: MicroBoost AI, ChemPass AI, and GeneRator AI, each targeting different core components for product development [3] Subsidiaries and Focus Areas - Biomica Ltd. focuses on microbiome-based therapeutics for human disorders using MicroBoost AI [3] - Lavie Bio Ltd. develops microbiome-based ag-biologicals, also powered by MicroBoost AI [3] - AgPlenus Ltd. is dedicated to next-generation agricultural chemicals for sustainable crop protection using ChemPass AI [3] - Casterra Ag Ltd. markets high-yield castor seed varieties for biofuel and other industries, utilizing GeneRator AI [3]